Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart H Orkin

Showing results (51-60 of 331) with videos related to

Pageof 34
Sort By:
Current Opinion in Genetics & Development|September 17, 2015
Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobinDaniel E Bauer, Stuart H Orkin
Blood|April 8, 2016
Customizing the genome as therapy for the β-hemoglobinopathiesMatthew C Canver, Stuart H Orkin
Nature Immunology|March 29, 2002
Hematopoiesis and stem cells: plasticity versus developmental heterogeneityStuart H Orkin, Leonard I Zon
Methods (San Diego, Calif.)|June 11, 2002
The use of altered specificity mutants to probe specific protein-protein interactions involved in the activation of GATA-1 target genesJohn D Crispino, Stuart H Orkin
Genome Medicine|May 14, 2009
Musings on genome medicine: gene therapyDavid G Nathan, Stuart H Orkin
Genome Medicine|May 15, 2009
Musings on genome medicine: cancer genetics and the promise of effective treatmentDavid G Nathan, Stuart H Orkin
Genome Medicine|April 8, 2009
Musings on genome medicine: genome wide association studiesDavid G Nathan, Stuart H Orkin
Development (Cambridge, England)|September 14, 2006
The journey of developing hematopoietic stem cellsHanna K A Mikkola, Stuart H Orkin
Genes & Development|February 5, 2002
The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineagesShireen Saleque, Scott Cameron, Stuart H Orkin
Methods in Molecular Medicine|October 20, 2004
Gene targeting and transgenic strategies for the analysis of hematopoietic development in the mouseHanna K A Mikkola, Stuart H Orkin
Pageof 34

Showing results (51-60 of 331) with videos related to

Sort By:
Pageof 34
Current Opinion in Genetics & Development|September 17, 2015
Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobinDaniel E Bauer, Stuart H Orkin
Blood|April 8, 2016
Customizing the genome as therapy for the β-hemoglobinopathiesMatthew C Canver, Stuart H Orkin
Nature Immunology|March 29, 2002
Hematopoiesis and stem cells: plasticity versus developmental heterogeneityStuart H Orkin, Leonard I Zon
Methods (San Diego, Calif.)|June 11, 2002
The use of altered specificity mutants to probe specific protein-protein interactions involved in the activation of GATA-1 target genesJohn D Crispino, Stuart H Orkin
Genome Medicine|May 14, 2009
Musings on genome medicine: gene therapyDavid G Nathan, Stuart H Orkin
Genome Medicine|May 15, 2009
Musings on genome medicine: cancer genetics and the promise of effective treatmentDavid G Nathan, Stuart H Orkin
Genome Medicine|April 8, 2009
Musings on genome medicine: genome wide association studiesDavid G Nathan, Stuart H Orkin
Development (Cambridge, England)|September 14, 2006
The journey of developing hematopoietic stem cellsHanna K A Mikkola, Stuart H Orkin
Genes & Development|February 5, 2002
The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineagesShireen Saleque, Scott Cameron, Stuart H Orkin
Methods in Molecular Medicine|October 20, 2004
Gene targeting and transgenic strategies for the analysis of hematopoietic development in the mouseHanna K A Mikkola, Stuart H Orkin
Pageof 34